SciSparc Registers 2.56M Shares for Resale, Potential 440% Dilution
SPRC has more than doubled off its 52-week low of $2.98.
Summary
SciSparc's F-3/A registers 2.56M shares for resale, revealing potential 440% dilution if all convertible note and warrant shares are issued.
Key Events · Financing and Capital Events · SPRC
-
Resale Registration of 2.56M Shares
Amendment No. 1 to Form F-3 registers up to 2,559,736 ordinary shares for resale by selling shareholders, consisting of 2,040,964 Note Shares, 405,728 Warrant Shares, and 113,044 Pre-Funded Warrant Shares.
-
Potential 440% Dilution
If all registered shares are issued, outstanding shares would increase from 580,973 to 3,140,709, representing approximately 440% dilution for existing shareholders.
-
Deep Discount Conversion Terms
The Initial Promissory Note converts at the lower of $5.517 fixed price or 88% of the lowest VWAP over 20 days, with a floor of $1.107 — far below the current stock price of $6.86, enabling the note holder to sell at a significant discount.
-
Financing Structure Details
The SPA provides for up to $10 million in convertible notes ($9 million purchase price). The Initial Note of $2.0 million was issued for $1.8 million, with additional notes of up to $2.5 million per quarter available at the company's discretion.
Analysis · SPRC · Life Sciences
SciSparc's Amendment No. 1 to its F-3 registration statement registers for resale up to 2,559,736 ordinary shares issuable upon conversion of a $2.0 million convertible note and exercise of related warrants. The filing reveals that if all registered shares are issued, the company's outstanding share count would rise from 580,973 to 3,140,709 — a potential dilution of approximately 440% for existing shareholders. The conversion price floor of $1.107 is significantly below the current stock price of $6.86, meaning the note holder can convert at a deep discount and sell into the market, creating substantial overhang. This is a material update to the original F-3 filed in February 2026, as it now quantifies the exact share counts and dilution impact.
How filings like this one have moved
In the 30 days to Aug 23, 2026, 29.5% of the 2875 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.02%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, SPRC was trading at $6.86 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.9M. The 52-week trading range was $2.98 to $80.10. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.